CD177 and neoplasm: Accumulating evidence supports the concept that platelets and tumour cells, through direct cellular contact, maintain reciprocal interactions within the tumour microenvironment where bidirectional cross-talk between tumour cells and platelets activates cell surface receptors, the release of soluble proteins, and the shedding of microparticles by platelets.